Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-072595·Endeavour Medtech Growth II LP
Schedule 13G ownership disclosure
KESTRA MED TECHNOLOGIES LTD
Common Shares, par value $1.00 per share · CUSIP: G52441105
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Endeavour Medtech Growth II LP
Shares: 2,646,899 · Class: 5.2%
- Endeavour Medtech Growth II Parallel LP
Shares: 2,646,899 · Class: 5.2%
- Endeavour Medtech II GP Limited
Shares: 2,646,899 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-072595
- Form type
- SCHEDULE 13G
- Filer
- Endeavour Medtech Growth II LP
- CIK
- CIK 1873032
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership